DENYES NANCY - Insider Non-Derivative Transactions at aTYR PHARMA INC (LIFE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 5, 2024, DENYES NANCY's relationship to aTYR PHARMA INC (LIFE) is Officer (General Counsel), and currently has 14,767 shares of Common stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LIFE insiders.
Data Source: SEC.
DENYES NANCY - Insider Non-Derivative Transactions of LIFE Common stock
DENYES NANCY - Insider Non-Derivative Transactions at LIFE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 6, 2024 | M -- (Common stock) | 2688 | 0 | 14767 |
| Feb 4, 2023 | M -- (Common stock) | 2688 | 0 | 7079 |